|
Code
|
3449C
|
|
MA number
|
EU/1/16/1157/002
|
|
Product Form:
|
sol inj 5x300 U/3 ml + 150 µg/3 ml (náplň skl. v pere)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Sanofi Winthrop Industrie, France
|
|
Therapeutic Class:
|
18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
|
|
ATC:
|
| A |
ALIMENTARY TRACT AND METABOLISM |
| A10 |
DRUGS USED IN DIABETES |
| A10A |
INSULINS AND ANALOGUES |
| A10AE |
Insulins and analogues, for injection, long-acting |
| A10AE54 |
Insulin glargine and lixisenatide |
|
|
Shelf life:
|
36 |
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
